Sohail Mohammed sworn in
NEW JERSEY,NJ–Indian born Sohail Mohammed was sworn in on July 1st as a Superior Court judge in Passaic County. He is the first Indian-American judge in New Jersey. He is also probably the first Muslim judge in the state.
Born in Hyderabad, Mohammed came to the U.S. with his parents when he was 17. He graduated with a degree in electrical engineering in 1988 from the New Jersey Institute of Technology, and then worked full-time for GEC-Marconi Electronic Systems in New Jersey.
At the same time, he worked on his law degree at the Seton Hall University School of Law in Newark, N.J. doing evening classes.
In 2009, he was named among the 101 most influential people in New Jersey by the New Jersey Monthly magazine. He was on the New Jersey â€œSuper Lawyerâ€ list six years running from 2006 to 2011.
Faheem Zaman bags Thiel Fellowship
NEW YORK,NY–Paypal founder Peter Thielâ€™s Thiel Foundation has announced its first batch of 20 under 20 fellows. The fellowship awards $100,000 to teenagers to drop out of higher education for two years and invest the time in innovation and entrepreneurship.
Among the fellows is Faheem Zaman who has shot the moon on nearly every SAT test heâ€™s ever taken: 5580 points across 5 tests. He wants to decentralize banking in the developing world with a mobile payment system. Because savings are difficult in poor countriesâ€”including in some regions of South Asia where many have to hoard and protect cashâ€”Faheem believes mobile financial services will help bring prosperity to these areas. Before he introduces his technology to the developing world, Faheemâ€™s initial plan is to gain a foothold in the U.S. market for mobile financial services.
Ayman Khan wins water scholarship
LONG ISLAND,NY–Lynbrook High School students Ayman Khan wAS awarded a $2,500 scholarship in a recent ceremony in Albany by Long Island American Water. She is one of the two local winners of the National Association of Water Companies New York Chapter (NAWC-NY) Scholarship program.
Both students showed a bold passion for the environment and the water industry through their applications and essays,â€ said William Varley, chairman of the NAWC-NY and President of Long Island American Water. â€œThese students displayed great potential, and we are excited to award each of them a scholarship to help in their pursuit to achieving success in the water industry.â€
The NAWC-NY launched this scholarship program for high school seniors interested in pursuing a career in the water utility industry or related fields. As a member of NAWC-NY, Long Island American Water offered two scholarships to high school students in its service area who will be attending a university or college in New York and pursuing a degree related to the water utility industry or related field.
Ayman Khan will be attending the City College of New York in the fall. She has held leadership roles in numerous organizations, including serving as President of Students Taking Active Roles (START) and Secretary of Students Against Destructive Decisions (SADD). She has also received numerous awards including the Long Island Science Congress Merit Award, Discus Award and Presidentâ€™s Volunteer Award
Khan leaving Samsung for Citibank
NEW YORK,NY–The Chief Technology Officer at Samsung Mobileâ€™s USA group, Omar Khan, has announced that he is leaving the company for a position at Citibank heading up the financial companyâ€™s global mobile efforts. Khan led the unveiling of the revised Galaxy Tab 10.1 and 8.9 tablets on stage at CTIA for Samsung earlier this year, as he has done for many of Samsungâ€™s mobile devices over the past three years. Khan formerly worked as a VP for Motorola before joining Samsung. In the recent past Khan often introduced the companyâ€™s tablets and Galaxy phones at events.
At Citibank he will reportedly be leading its mobile initiatives.
Dr. Maha Hussain leads study on prostate cancer drug
A study led by Dr. Maha Hussain shows that a prostate cancer drug may prevent bone metastatis, reports the Renal and Urology News. The promising results for cabozantinib, a new therapeutic agent for castration-resistant prostate cancer (CRPC), particularly against tumors that have metastasized to the bone. In a phase 2 study of men (median age 68 years) with metastatic CRPC (mCRPC) who were followed for a median of four months, 47% of the 100 evaluable patients had undergone prior treatment with docetaxel. Seventy-eight percent had bone metastasis. Among the 65 patients evaluable by bone scan, 56 (86%) experienced complete or partial resolution of bone lesions as early as week 6 of cabozantinib treatment. In addition, 64% of the 28 men receiving narcotics for bone pain had improved pain relief, with narcotics reduced or halted in 46%. By week 12, the disease control rate was 71%. Cabozantinib, an inhibitor of the MET and VEGF pathways, showed clinical activity regardless of prior docetaxel therapy.